AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
基本信息
- 批准号:7689549
- 负责人:
- 金额:$ 25.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-29 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-Kinase11p15q20q3q213q22.23q22.33q285-(6)-carboxyfluorescein diacetate succinimidyl ester90YAIDS Malignancy ConsortiumAIDS VaccinesAIDS and Cancer Specimen BankAIDS chemotherapyAIDS clinical trial groupAIDS diagnosisAIDS epidemiologyAIDS related cancerAIDS related neoplasmAIDS therapyAIDS with Kaposi&aposs sarcomaAIDS-Related Burkitt&aposs LymphomaAIDS-Related DisorderAIDS-Related Hodgkin&aposs LymphomaAIDS-Related LymphomaAIDS-Related Non-Hodgkin&aposs LymphomaAIDS-Related Primary Central Nervous System LymphomaAbbreviationsAbdomenAberrant DNA MethylationAblationAcademic Medical CentersAcademyAccountabilityAccountingAcquired Immunodeficiency SyndromeAcuteAcute T Cell LeukemiaAddressAdherenceAdjuvantAdministratorAdoptedAdoptive TransferAdrenal Cortex HormonesAdultAdult Burkitt&aposs LymphomaAdvanced Malignant NeoplasmAdverse effectsAdverse eventAdvisory CommitteesAdvisory ServicesAdvocacyAdvocateAffectAffinityAfricaAfrica South of the SaharaAfricanAfrican AmericanAfrican Burkitt&aposs lymphomaAftercareAgeAge-YearsAggressive behaviorAgingAgreementAgricultureAlabamaAldesleukinAlgorithmsAll SitesAllergic ReactionAlternative MedicineAmendmentAmericanAmerican College of SurgeonsAmerican Society of Clinical OncologyAnal Intraepithelial NeoplasiaAnal canalAnal carcinomaAnemiaAnestheticsAngiogenesis InhibitionAngiogenesis InhibitorsAngiogenic FactorAnnexinsAnogenital Human Papilloma Virus InfectionAnogenital cancerAnogenital venereal wartsAnthracycline AntibioticsAnthracyclinesAnti-Retroviral AgentsAntibodiesAntibody AffinityAnticonvulsantsAntigen TargetingAntigensAntineoplastic AgentsAntiretroviral resistanceAntisense OligonucleotidesAntiviral AgentsAntiviral TherapyAntsAnusAplastic AnemiaApoptosisApoptoticAppearanceAppendixApplications GrantsAppointmentArchivesAreaArginine ButyrateArthralgiaArtsAryl Hydrocarbon ReceptorAscaridilAspirate substanceAstheniaAttentionAustraliaAuthorization documentationAutologousAutologous Stem Cell TransplantationAutomobile DrivingAwardAzacitidineB Cell ProliferationB lymphoid malignancyB-Cell ActivationB-Cell LymphomasB-Cell NeoplasmB-Cell NonHodgkins LymphomaB-LymphocytesBCL2L1 geneBMS-275291Bacterial InfectionsBasement membraneBasic ScienceBehaviorBenchmarkingBenefits and RisksBindingBioavailableBiochemicalBioethicsBioinformaticsBiologic CharacteristicBiologicalBiological AssayBiological FactorsBiological MarkersBiologyBiomedical ResearchBiometryBiopsyBiopsy SpecimenBisexualBlindedBloodBlood CellsBlood PlateletsBlood VesselsBlood capillariesBlood donorBlood donor screeningBlood specimenBolus InfusionBone MarrowBone Marrow DiseasesBone Marrow SuppressionBook ChaptersBooksBortezomibBos taurusBostonBowen&aposs DiseaseBowenoid PapulosisBoxingBrainBrassicaceaeBrazilBreast FeedingBritish ColumbiaBryostatin 1/VincristineBudgetsBurkitt LymphomaBurn injuryBusiness RulesBusinessesBusulfanBylawBypassCCI-779CD3 AntigensCD34 geneCD4 Lymphocyte CountCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCDE protocol-cyclophosphamide/doxorubicin/etoposideCHK geneCI-1040COL-3CT2103CXCL13 geneCYP2D6 geneCYP3A4 geneCalendarCaliforniaCameroonCancer CenterCancer EtiologyCancer PatientCancer Research ProjectCancer Therapy Evaluation ProgramCancer Trials Support UnitCancer VaccinesCancer cell lineCancer-Related ConditionCapitalCapsidCarcinomaCarcinoma in SituCardiovascular systemCaringCarmustine/Cisplatin/EtoposideCase Report FormCase StudyCaspaseCatalytic RNACategoriesCathetersCattleCause of DeathCell CountCell CycleCell Cycle ProgressionCell DeathCell FractionCell LineCell NucleusCell ProliferationCell SurvivalCellsCellular ImmunityCensusesCentral Nervous System LymphomaCentral Nervous System ProphylaxisCentrosomeCerebrospinal FluidCertificationCervicalCervical Intraepithelial NeoplasiaCervical dysplasiaCervix UteriCervix carcinomaCessation of lifeCetuximabChairpersonCharacteristicsChargeChelating AgentsChemicalsChemosensitizationChemotherapy-Oncologic ProcedureChicagoChickensChildChildhoodChildhood Non-Hodgkin&aposs LymphomaChileChimeric ProteinsChinChinaCholine KinaseChromosomal InstabilityChromosomal translocationChromosome ArmChromosomesChromosomes, Human, Pair 8ChronicChronic Lymphocytic LeukemiaChronic Myeloid LeukemiaCidofovirCisplatinCisplatin/Cytarabine/Etoposide/MethylprednisoloneCisplatin/MitomycinCitiesCivil RightsClassClassificationClinicClinicalClinical DataClinical Data Update SystemClinical EngineeringClinical EthicsClinical InvestigatorClinical ManagementClinical ProtocolsClinical ResearchClinical Research AssociateClinical TreatmentClinical TrialsClinical Trials Cooperative GroupClinical Trials Data Monitoring CommitteesClinical Trials DesignClinical Trials NetworkClinical effectivenessClonal ExpansionClonalityCloningClosureCluster AnalysisCoagulation ProcessCoccidiosisCocosCodeCoffeeCohort StudiesCoinCold TherapyCollaborationsCollagen Type ICollectionColonColon CarcinomaColon, RectumColoradoColorectalColorectal CancerColostomy ProcedureColposcopyCombination ChemotherapyCombined Modality TherapyCombivirCombretastatin A-4Combretastatin A4 Disodium PhosphateCombretastatin A4 PhosphateCommerceCommitCommittee MembersCommittee MembershipCommon Data ElementCommon Terminology Criteria for Adverse EventsCommunicable DiseasesCommunicationCommunitiesCommunity Clinical Oncology ProgramCommunity OutreachCommunity PhysicianCommunity RelationsCompanionsComparative StudyComplementary DNACompletion StatusComplexComprehensive Cancer CenterComputer SystemsComputer Systems DevelopmentComputer softwareComputersConditionConduct Clinical TrialsConfidence IntervalsConfidential InformationConfidentiality of Patient InformationConflict (Psychology)Conflict of InterestConjunctival Squamous Cell CarcinomaConsensusConsentConsent FormsConsultationsContinuous Ambulatory Peritoneal DialysisContinuous InfusionContract ServicesContractsControlled StudyContusionsCore FacilityCorrelation StudiesCorrelative StudyCosmeticsCost AllocationCost SharingCounselingCountCountryCountyCouplesCreamCremophorCross-Sectional StudiesCutaneousCutaneous InvolvementCyclin D1CyclophosphamideCyclophosphamide/Doxorubicin/Etoposide/Prednisone/VincristineCyclosporinsCytarabineCytidine DeaminaseCytochrome P450CytologyCytology HistologyCytomegalovirusCytomegalovirus RetinitisCytotoxic ChemotherapyCytotoxic T-LymphocytesDM-EtDNADNA FingerprintingDNA IntegrationDNA SequenceDNA Sequence RearrangementDNA copy numberDNA-Directed DNA PolymeraseDailyDataData AnalysesData CollectionData QualityData ReportingData SetDatabasesDeath RateDebridementDecision MakingDecision Support SystemsDefectDefective spinal cord developmentDeglutition DisordersDementiaDental ResearchDeoxyribonuclease IDeoxyribonucleasesDepositionDerivation procedureDermalDermatologicDetectionDeveloped CountriesDeveloping CountriesDevelopmentDevelopment PlansDevelopmental Therapeutics ProgramDevicesDiagnosisDiagnosticDiagnostic ImagingDiagnostic Neoplasm StagingDiagnostic ProcedureDiarrheaDidanosineDifferentiation AntigensDiffuseDiffuse Large-Cell LymphomaDigestionDigit structureDigital Rectal ExaminationDirect CostsDisabled PersonsDiscriminationDiseaseDisease OutcomeDisease ProgressionDisease regressionDisease remissionDisease-Free SurvivalDisorder by SiteDisputesDisruptionDisseminated eosinophilic collagen diseaseDistantDistrict of ColumbiaDocetaxel/ThalidomideDoctor of MedicineDoctor of PhilosophyDocumentationDominant-Negative MutationDoseDose-LimitingDouble-Blind MethodDown-RegulationDoxorubicinDoxorubicin/EtoposideDoxorubicin/MethotrexateDoxorubicin/PaclitaxelDropsDrug ApprovalDrug Delivery SystemsDrug EvaluationDrug FormulationsDrug InteractionsDrug KineticsDrug abuseDrug resistanceDrug usageDysmyelopoietic SyndromesDysplasiaE-SelectinEBV-associated malignancyEGF geneESHAP regimenEarly treatmentEastern Cooperative Oncology GroupEdemaEducationEducational workshopEffectivenessEffectiveness of InterventionsElectrocoagulationElectronicsElementsEligibility DeterminationEmergency SituationEmerging Communicable DiseasesEmployeeEncapsulatedEnd PointEndocrinologyEndopeptidasesEndothelial CellsEndpoint DeterminationEnrollmentEnsureEnvironmentEnvironment DesignEnzyme-Linked Immunosorbent AssayEnzymesEpidemicEpidemiologic StudiesEpidemiologistEpidemiologyEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpithelialEpithelial CellsEpithelial ovarian cancerEpitheliumEpstein-Barr Virus InfectionsEpstein-Barr Virus latencyEpstein-Barr Virus-Related LymphomaEquipmentEquipment and supply inventoriesErbB Receptor Family ProteinErythrocytesErythropoietinEstrogensEtanerceptEthicistsEthicsEtiologyEtoposideEtoposide/IfosfamideEuropeEvaluationEvaluation ReportsEventEvidence Based MedicineEvolutionExanthemaExcisionExhibitsExonsExpenditureExposure toExtracellular MatrixExtracellular Signal Regulated KinasesExtramural ActivitiesExtranodalEye diseasesFaceFacilities and Administrative CostsFacultyFailureFamilyFamily memberFarming environmentFatigueFeedbackFeesFemaleFetusFeverFibrinogenFibroblast Growth FactorFibroblast Growth Factor 2Figs - dietaryFilgrastimFinancial compensationFloridaFlow CytometryFlowersFluorouracilFocus GroupsFollow-Up StudiesForensic MedicineFormalinFosteringFoundationsFoxesFranceFraudFreezingFrequenciesFriendsFringe BenefitFunctional disorderFundingFunding AgencyFunding MechanismsFunding OpportunitiesFutureG-Protein-Coupled ReceptorsGamma RaysGanciclovirGanciclovir/Interleukin-2/ZidovudineGastrointestinal NeoplasmsGastrointestinal Stromal TumorsGaysGelGelatinase AGelatinase BGenderGene ExpressionGene Expression ProfilingGene TargetingGene TransferGene-ModifiedGeneral HospitalsGeneral PopulationGenerationsGeneric DrugsGenesGeneticGenetic PolymorphismGenetic TranscriptionGenomeGenomic InstabilityGenomicsGenotypeGenus CapraGenus ColaGeographyGhanaGillsGlareGlassGleevecGlycolysisGlycoproteinsGoalsGovernmentGraft RejectionGrantGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorGroup AffiliationGroup MeetingsGrowthGrowth FactorGuidelinesGynecologic OncologistGynecologistGynecologyHIF1A geneHIVHIV prevention trials networkHIV-1HairHalf-LifeHalofuginoneHalofuginone HydrobromideHandHarvestHawaiiHeadHead and Neck CancerHead and Neck Squamous Cell CarcinomaHeadacheHealthHealth Insurance Portability and Accountability ActHealth SciencesHealth Services ResearchHealthcareHealthcare SystemsHearingHeatingHelper-Inducer T-LymphocyteHelsinki DeclarationHemangiosarcomaHematologic NeoplasmsHematologistHematologyHematopoietic Cell Growth FactorsHematopoietic Stem Cell MobilizationHematopoietic stem cellsHemorrhageHemorrhoidsHemosiderin DepositionHepaticHepatitis C virusHerpesviridaeHerpesviridae InfectionsHeterosexualsHigh PrevalenceHighly Active Antiretroviral TherapyHistologicHistologyHistone DeacetylaseHistone Deacetylase InhibitorHistopathologyHodgkin DiseaseHollyHome environmentHomologous GeneHomosexualsHospital DepartmentsHospitalsHourHousingHspE7HumanHuman Chorionic GonadotropinHuman Herpesvirus 4Human Herpesvirus 8Human PapillomavirusHuman ResourcesHuman T-lymphotropic virus 1Human immunodeficiency virus testHuman papilloma virus infectionHuman papillomavirus 16Human papillomavirus 6Humoral ImmunitiesHybridsHydroxylationHypergammaglobulinemiaHyperplasiaHypertensionHypoxiaHypoxia Inducible FactorIL2 geneIL6 geneIbritumomab TiuxetanIgEImageImatinibImatinib mesylateImiquimodImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunizationImmunoblastImmunoblottingImmunocompetentImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin Somatic HypermutationImmunoglobulin Variable RegionImmunoglobulinsImmunohistochemistryImmunologic Deficiency SyndromesImmunologic MarkersImmunologicsImmunologistImmunologyImmunophenotypingImmunosuppressionImmunotherapeutic agentImmunotherapyImplantIn Situ HybridizationIn VitroIn complete remissionIncentivesIncidenceIncidence StudyIncomeIndinavirIndinavir/Lamivudine/StavudineIndividualInduction of ApoptosisIndustryInfantInfectionInfectious AgentInferiorInflammatoryInformation DisseminationInformation DistributionInformation SystemsInformation TechnologyInformed ConsentInfusion proceduresInjection Site ReactionInjection of therapeutic agentInstitutesInstitutionInstructionInsulin-Like Growth Factor IIntegral Membrane ProteinIntentionInterferon Alfa-2aInterferon Alfa-2bInterferon-alphaInterferonsInterleukin 2 ReceptorInterleukin 6 ReceptorInterleukin-1Interleukin-10Interleukin-12Interleukin-13Interleukin-2Interleukin-3Interleukin-4Interleukin-6InternationalInternational AIDSInternational Agency for Research on CancerInternational AspectsInternational Prognostic IndexInternational UnitInternetInterventionIntervention StudiesIntraepithelial NeoplasiaIntravenousIntravenous infusion proceduresInvasiveInvestigationInvestigational DrugsIrelandIslandIsotretinoinIsraelJNK-activating protein kinaseJointsJournal of the National Cancer InstituteJournalsJusticeKaposi SarcomaKarnofsky Performance StatusKenyaKidneyKidney DiseasesKidney FailureKidney TransplantationKnowledgeLabelLaboratoriesLaboratory ResearchLaboratory StudyLactate DehydrogenaseLamivudine/ZidovudineLaparotomyLarge-Cell Immunoblastic LymphomaLarge-Cell LymphomasLasersLatin AmericaLawsLawyersLeadLeadershipLearningLeftLegal patentLengthLesionLesion by StageLettersLeucovorinLibrariesLicensingLifeLife Cycle StagesLigandsLigationLightLightheadednessLinkLiposomal DoxorubicinLiposomesLiquid substanceLiteratureLiver DysfunctionLiver Function TestsLobbyingLocationLogisticsLong-Term EffectsLos AngelesLow PrevalenceLungLung Kaposi&aposs SarcomaLymphaticLymphatic EndotheliumLymphocyteLymphocyte ActivationLymphocyte CountLymphocyte FunctionLymphocyte antigenLymphoidLymphomaLymphomagenesisLymphopeniaLymphoproliferative DisordersLyticLytic PhaseMAP Kinase GeneMAPK14 geneMEKsMME geneMS4A1 geneMagnetic Resonance ImagingMailsMaintenanceMaizeMalawiMalignant - descriptorMalignant NeoplasmsMalignant Squamous Cell NeoplasmMalignant lymphoid neoplasmMalignant neoplasm of anusMalignant neoplasm of cervix uteriMalignant neoplasm of gastrointestinal tractMalignant neoplasm of lungMalignant neoplasm of ovaryManualsManuscriptsMarrowMarylandMassachusettsMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMaximum Tolerated DoseMeasurementMeasuresMediatingMediationMedicalMedical HistoryMedical OncologistMedical OncologyMedical RecordsMedical ResearchMedical centerMedicineMelanocytic nevusMeleagris gallopavoMembrane ProteinsMemorial Sloan-Kettering Cancer CenterMental HealthMentorsMessenger RNAMetabolicMetabolic Clearance RateMetabolic PathwayMetadataMethodologyMethodsMethotrexateMethylationMicroarray AnalysisMicrobiologyMid-Career Clinical Scientist Award (K24)MindMinorMinorityMissionMitogen-Activated Protein Kinase InhibitorMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensMitomycinMitoticMitotic spindleModalityModelingMole the mammalMolecularMolecular BiologyMolecular EpidemiologyMolecular ProfilingMolecular TargetMonitorMonoclonal AntibodiesMonoclonal Antibody C225MononuclearMoodsMorbidity - disease rateMossesMucositisMulti-Institutional Clinical TrialMulticenter StudiesMulticenter TrialsMulticentric Angiofollicular Lymphoid HyperplasiaMultidrug Resistance GeneMultinational PerspectivesMultiple MyelomaMultivariate AnalysisMusMutationMycobacterium bovisMycobacterium heat-shock protein 65MycosesMyelogenousMyelopoiesisMyelosuppressionMyelosuppressive TherapyN(delta)-acetylornithine, -isomerN-dodecanoylglutamic acid, -isomer, sodium saltNF-kappa BNamesNasopharynx CarcinomaNational Cancer InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of Mental HealthNatural HistoryNatural Killer CellsNatureNeedlesNeeds AssessmentNeoadjuvant TherapyNeoplasmsNeurologicNeurologyNeuropathyNeutropeniaNew AgentsNew YorkNew York CityNewly DiagnosedNewsletterNewspapersNitrogenNodalNodular LesionNon-Hodgkin&aposs LymphomaNon-Small-Cell Lung CarcinomaNone or Not ApplicableNormal tissue morphologyNorth CarolinaNot DefinedNotificationNuclearNucleosidesNude MiceNumbersNursesNursing ResearchObject AttachmentObstetrics DepartmentsOccupational activity of managing financesOffice ManagementOffice of ManagementOhioOintmentsOkadaic AcidOligonucleotidesOncogene ActivationOncogene ProteinsOncogenesOncogenicOncogenic VirusesOncologistOncology GroupOnline SystemsOpen Reading FramesOperating RoomsOperative Surgical ProceduresOpportunistic InfectionsOralOrganOrgan TransplantationOther Agency or OrganizationOther Working GroupsOutcomeOutcome MeasureOutcome StudyOutpatientsOxygenPDGF inhibitionPDGFRB genePIK3CA genePIK3CB genePTPRC genePaclitaxelPainPalate Kaposi&aposs SarcomaPalpablePaperPapillomavirusParaffin EmbeddingParaffin TissueParentsPartial RemissionParticipantPathogenesisPathologicPathologistPathologyPathway interactionsPatient CarePatient MonitoringPatient RecruitmentsPatient currently pregnantPatientsPatternPatterns of CarePediatric HospitalsPeer ReviewPennsylvaniaPeptide HydrolasesPeptidesPerformancePeripheral Blood Mononuclear CellPeripheral Nervous System DiseasesPersonal CommunicationPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacia brand of cidofovirPharmacistsPharmacodynamicsPharmacologic SubstancePharmacologyPhasePhase I Clinical TrialsPhase I/II TrialPhase II Clinical TrialsPhase III Clinical TrialsPhenotypePhorbol EstersPhosphatidylinositolsPhosphoinositide-3-Kinase, Catalytic, Beta PolypeptidePhosphorylationPhosphotransferasesPhotochemotherapyPhotosensitivityPhysician ExecutivesPhysiciansPhysiologic pulsePigmentation physiologic functionPike fishPilot ProjectsPlacebo ControlPlacebosPlanet MarsPlasmaPlatelet Count measurementPlatelet-Derived Growth FactorPlatelet-Derived Growth Factor ReceptorPlayPliabilityPodophyllotoxinPolandPoliciesPolyarthritidesPolymerasePolymerase Chain ReactionPolymersPopulationPopulation ControlPopulation GroupPopulation StudyPopulations at RiskPositioning AttributePositron-Emission TomographyPovertyPre-studyPrecancerous ConditionsPredictive FactorPredispositionPrednisonePregnancyPregnancy TestsPremalignantPremedicationPreparationPresbyterian ChurchPress ReleasesPrevalencePrevalence StudyPreventionPrevention approachPrevention strategyPreventivePrimary Care PhysicianPrimary Health CarePrimary NeoplasmPrimary carcinoma of the liver cellsPrincipal InvestigatorPrintingPrior ChemotherapyProceduresProcessProcollagen-Proline DioxygenaseProctitisProductionProductivityProfessional counselorPrognostic FactorPrognostic MarkerProgram Research Project GrantsProgram ReviewsProgress ReportsProgression-Free SurvivalsProgressive DiseaseProliferatingProlinePropertyProphylactic treatmentProspective StudiesProstate AdenocarcinomaProtease InhibitorProteasome InhibitorProtein IsoformsProtein Kinase CProtein OverexpressionProtein Tyrosine KinaseProteinsProteolysisProteomicsProto-Oncogene Protein c-kitProto-Oncogene Proteins c-aktProto-OncogenesProtocols documentationProviderPsychiatristPsychiatryPublic HealthPublicationsPublished CommentPublishingPulse takingPunch BiopsyPuncture procedurePurposeQualifyingQuality ControlQuality of lifeQuestionnairesRNARadiationRadiation Therapy Oncology GroupRadiation therapyRadioRadioimmunotherapyRadioisotopesRanaRandomizedRandomized Controlled Clinical TrialsRandomized Controlled TrialsRangeRateReactionReadingRebeccamycin AnalogueReceptor InhibitionReceptor Protein-Tyrosine KinasesReceptors, Antigen, B-CellRecombinant Granulocyte Colony Stimulating FactorRecombinant Interferon AlfaRecombinant Interleukin-2Recombinant ProteinsRecombinantsRecommendationRecording of previous eventsRecordsRecoveryRecruitment ActivityRectumRecurrenceRed CrossRefractoryRegistriesRegression AnalysisRegulationRelapseRelative (related person)Relative RisksReport (document)ReportingReproductionResearchResearch ActivityResearch ContractsResearch DesignResearch EthicsResearch Ethics CommitteesResearch InfrastructureResearch MethodologyResearch MisconductResearch PersonnelResearch PriorityResearch Project GrantsResearch SubjectsResearch SupportResearch TrainingResidual TumorsResidual stateResistanceResistance developmentResolutionResource AllocationResource SharingResourcesRespiratory FailureRespiratory InsufficiencyRestRestartRetinoidsRetrospective StudiesRetroviridaeReverse Transcriptase InhibitorsReverse Transcriptase Polymerase Chain ReactionReview CommitteeReview LiteratureRheumatoid ArthritisRightsRiskRisk FactorsRisk MarkerRitonavirRoleRolfingRoom, CleanRosaRotationRouteRunningRussiaRwandaSCID MiceSGN-00101 (HspE7)STI571SU 5416SafetySalaries and Fringe BenefitsSalvage TherapySample SizeSamplingSampling StudiesSan FranciscoSatellite VirusesScheduleScienceScoreScotlandScreening for cancerScreening procedureSecondary toSecureSeminalSenior ScientistSensitivity Training GroupsSensitivity and SpecificitySequence AnalysisSeriesSerious Adverse EventSerodiagnosesSerologic testsSerologicalSeroprevalencesSerumServicesSeveritiesSex FunctioningSexually Transmitted AgentsSexually Transmitted DiseasesShippingShipsSideSignal PathwaySignal TransductionSignal Transduction InhibitorSignal Transduction PathwaySignificance LevelSigns and SymptomsSimplexvirusSirolimusSiteSite VisitSkinSkin Kaposi&aposs SarcomaSlideSmall Business Funding MechanismsSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSmokeSmoking HistorySocietiesSolidSolid NeoplasmSolutionsSomatic MutationSourceSouth AfricaSpecialistSpecialized Program of Research ExcellenceSpecific qualifier valueSpecificitySpecimenSpecimen HandlingSquamous CellSquamous Cell NeoplasmsSquamous cell carcinomaSquamous intraepithelial lesionStagingStaging SystemStaining methodStainsStandards of Weights and MeasuresStatistically SignificantStem Cell FactorStem Cell ResearchStem cell transplantSterilization for infection controlStomatitisStrategic PlanningStratificationStructureStructure of germinal center of lymph nodeStudentsStudy SectionStudy SubjectSubgroupSuggestionSumSupervisionSupportive careSurfaceSurface ImmunoglobulinsSurgeonSurvey MethodologySurveysSurvival RateSuspension substanceSuspensionsSutentSwabSwellingSwitzerlandSymptomsSyncopeSyndromeSystemT memory cellT-LymphocyteTAF8 geneTNFRSF8 geneTNP470TP53 geneTSC1/2 geneTSC2 geneTamponsTanzaniaTaxane CompoundTdT-Mediated dUTP Nick End Labeling AssayTechniquesTechnologyTechnology TransferTeleconferencesTelefacsimileTelephoneTelephone NumberTelomeraseTemperatureTestingTetracyclineTetracyclinesTextbooksThalidomideTherapeuticTherapeutic AgentsTherapeutic Clinical TrialTherapeutic EffectTherapeutic Human ExperimentationTherapeutic InterventionTherapeutic StudiesTherapeutic immunosuppressionTherapy Clinical TrialsTherapy EvaluationThermographyThinkingThrombocytopeniaThymidineThymidine KinaseTimeTimeLineTissue BanksTissue MicroarrayTissue SampleTissue SurvivalTissuesToll-like receptorsTopical agentTopical applicationTouch sensationToxic effectTrainingTraining ProgramsTransactivationTranscriptTranscription Factor AP-1Transforming Growth Factor alphaTransforming Growth FactorsTransfusionTranslational ResearchTranslationsTransplant RecipientsTransplantationTravelTreatment EfficacyTreatment ProtocolsTreatment outcomeTriageTrichloroacetic AcidTubeTuberculosisTumor BankTumor BiologyTumor BurdenTumor Cell InvasionTumor Cell LineTumor Necrosis Factor-alphaTumor Necrosis FactorsTumor Suppressor ProteinsTumor TissueTumor-Infiltrating LymphocytesTurkey birdType I ProcollagenTyrosine Kinase InhibitorUbiquitinUbiquitinationUgandaUltrasonographyUmbilical Cord BloodUnited StatesUnited States Dept. of Health and Human ServicesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesUniversity HospitalsUp-RegulationUpdateUpper armUrsidae FamilyVEGFC geneVHL proteinVaccinatedVaccinationVaginal DouchingValidationValproic AcidVariantVascular Endothelial CellVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3Vascular Endothelial Growth FactorsVascular PermeabilitiesVascular ProliferationVeinsVelcadeVertebratesVeteransVinblastineVincristineViralViral AntigensViral GenesViral Load resultViral MarkersViral OncogeneViral PathogenesisViral load measurementViremiaVirginiaVirionVirusVirus ActivationVirus DiseasesVirus LatencyVirus ReplicationVirus-Related LymphomaVisceralVisible RadiationVisionVisitVocabularyVon Hippel-Lindau Tumor Suppressor ProteinVotingVulnerable PopulationsVulval intraepithelial neoplasiaWagesWalkersWashingtonWaterWeb communicationWeekWest IndiesWidespread DiseaseWolvesWomanWomen&aposs GroupWomen&aposs HealthWood materialWorkWorkplaceWorld Health OrganizationWritingXenograft ModelXenograft procedureXerostomiaXyotaxY 90 Ibritumomab TiuxetanYangZea maysZidovudineZimbabweabsorptionabstractingacquired immunodeficiencyactivation-induced cytidine deaminaseadjudicationage relatedalitretinoinalpha-difluoromethyl-DOPA, -isomeralpha-methylornithine dihydrochloride, -isomeranal canal Carcinomaanalogangiogenesisantiangiogenesis therapyanticancer researchantiretroviral therapyassay developmentastrinauthorityautocrinebasebcr-abl Fusion Proteinsbirth controlbleomycin/doxorubicin/vinblastine protocolbleomycin/doxorubicin/vincristine protocolbryostatinburden of illnessc-erbB-1 Proto-Oncogenesc-myc Genescancer Biomedical Informatics Gridcancer cellcancer diagnosiscancer immunotherapycancer preventioncancer riskcancer therapycapillarycapitate bonecarcinogenesiscareercase-basedcell growthcell killingcell mediated immune responsecell typecellular targetingcervical and anal cancerchemokinechemotherapeutic agentchemotherapychild bearingcisplatin/fluorouracil protocolcitrate carrierclinical efficacyclinical research siteclinically significantcohortcollegecomparative genomic hybridizationcomparative trialconceptconjunctivacooperative studycostcost effectivecost effectivenesscyclin-dependent kinase inhibitor 1Bcyclooxygenase 2cyclophosphamide/doxorubicin protocolcyclophosphamide/prednisone/vincristine protocolcysteine rich proteincytokinecytopeniacytotoxicdata acquisitiondata managementdata structuredaydemethylationdemographicsdensitydesigndigitaldisabilitydiscontinuation trialdisease natural historydosagedoxorubicin/etoposide/vincristine protocoldrug developmentdrug distributiondrug metabolismeditorialefflux pumpeffusionexpectationexperienceextracellularfallsfarmerfollow-upfootforgingfrailtyfundamental researchgene therapyglucose metabolismgranulocytegroup counselinghandbookhandicapping conditionhealthy volunteerhigh throughput screeninghuman FRAP1 proteinhuman PIK3CA proteinhuman TNF proteinhuman embryonic stem cellhuman fetus tissuehuman prostaglandin D2 receptorhuman stem cellshuman subjecthydroxyureahypoxia inducible factor 1immune functionimmunoregulationimprovedimproved functioningin vivoindexinginfluenzavirusinhibitor/antagonistinnovationinorganic phosphateinsightinstrumentinterestinvestigator trainingirinotecanirradiationkidney allograftkillingskinase inhibitorlarge cell Diffuse non-Hodgkin&aposs lymphomalatency-associated nuclear antigenlatent nuclear antigenlecturerlecturesleukemialeukemia/lymphomalorislymphoid hyperplasialymphoid neoplasmlytic gene expressionlytic replicationmacrophagemalemalignant breast neoplasmmalignant mouth neoplasmmecarzolemedical schoolsmedical specialtiesmelanomamembermenmen who have sex with menmetastatic colorectalmetastatic processmicrobicidemigrationmolecular pathologymonocytemortalitymouse modelmulticatalytic endopeptidase complexmycobacterialmycophenolate mofetilneoplasm registryneoplasticneoplastic cellneovascularizationneutrophilnewsnon-nucleoside reverse transcriptase inhibitorsnovelnovel strategiesnovel therapeuticsnucleoside analogolder patientoncologyoptical imagingorganizational structureoutcome forecastovarian neoplasmoxaliplatinp27 Cell Cycle Proteinp27 Enzyme Inhibitorp65pandemic diseaseparacrineparkin gene/proteinpartial responsepathogenpatient safetypaymentpeerpenisperformance siteperipheral bloodpilot trialplacebo controlled studyplatelet-derived growth factor BBpol genesposterspre-clinicalpreclinical studypreconditioningpreventprofessorprogenitorprogesterone 11-hemisuccinate-(2-iodohistamine)prognosticprogramspromoterprospectiveprotein expressionprotocol developmentquality assuranceradiation resistancerandomized placebo controlled trialranpirnasereceptorreceptor downregulationreceptor expressionreconstitutionrepairedrepositoryresearch and developmentresearch clinical testingresearch studyresponserituximabrural areasample collectionsarcomascalpelsecretasesevinsexsizeskillsskin discolorationskin disordersoftware developmentsoundsouthern hybridizationstatistical centerstatisticsstemstudy characteristicssubcutaneoussuccesssymposiumtat Proteintaxanetherapeutic targettherapeutic vaccinetherapy developmenttissue culturetoe corntooltraffickingtranscription factortranslational studytransmission processtreatment durationtreatment effecttreatment trialtrendtumortumor growthtumor necrosis factor receptor superfamily, member 10b protein, mousetumor progressiontumor xenograftuptakeurologicviral DNAviral RNAviral cyclinvirologyvirus identificationvirus related cancervirus related neoplasmvolunteerward
项目摘要
DESCRIPTION (provided by applicant): The Group Chair' office of the AIDS Malignancy Consortium (AMC) is located in the UCLA Center for Clinical AIDS Research and Education (CARE Center), located at 9911 Pico Blvd, Ste 980, Los Angeles, CA 90035. The AMC is a clinical trials cooperative group established to evaluate new clinical interventions for the treatment and prevention of malignancies in HIV. The mission of the AMC is to improve the therapy of malignancies in HIV and to develop new and more effective treatment and prevention approaches. Dr. Ronald Mitsuyasu, the AMC Group Chair, is Director of the UCLA CARE Center and Professor of Medicine in the Division of Hematology-Oncology at UCLA. Dr. Mitsuyasu is responsible for the coordination, overall function, scientific direction, and fiscal accountability of the AMC. With input from the AMC working groups, Executive Committee and NCI Program Director, he sets the scientific agenda and oversees the execution of the AMC's protocols and other scientific endeavors. He chairs all meetings and conference calls of the Executive and Steering Committees, interacts with all components of the AMC and is the primary representative of the group to other oncology and HIV clinical trials groups, the AIDS Cancer and Specimen Resource (ACSR) and the NIAID Managing Partner Committee. Dr. Mitsuyasu will be assisted by a Project Manager who will coordinate the functions of the various group components and will maintain communications between the Group Chair and the sites, operations center, statistics center and core labs. She will also represent the Group Chair on working group calls and review protocols for accuracy and completeness prior to their being released to the sites. A project assistant will arrange and take minutes for all AMC conference calls and perform secretarial duties for the Group Chair and Project Manager. A project analyst will be responsible for monitoring all aspects of the finances of the group and preparing fiscal reports for the NCI.
Malignancies are a growing problem in immune deficient HIV patients, and cancer remains one of the major causes of morbidity and mortality in AIDS patients. The AIDS Malignancy Consortium (AMC) conducts studies to improve the treatment of cancers in HIV disease. The AMC Group Chair's office is responsible for coordinating and overseeing all aspects of the functioning of the AMC.
描述(由申请人提供):艾滋病恶性财团(AMC)的小组主席办公室位于UCLA临床艾滋病研究和教育中心(CARE CENTER(CARE CENTER),位于9911 Pico Blvd,Ste 980,洛杉矶,CA 90035。 AMC的任务是改善艾滋病毒恶性肿瘤的治疗,并开发新的,更有效的治疗方法和预防方法。 AMC集团主席Ronald Mitsuyasu博士是UCLA护理中心主任,也是UCLA血液肿瘤学系的医学教授。 Mitsuyasu博士负责AMC的协调,整体功能,科学方向和财政责任制。在AMC工作组,执行委员会和NCI计划主管的意见下,他设定了科学议程,并监督了AMC协议和其他科学努力的执行。他主持了执行和指导委员会的所有会议和会议,与AMC的所有组成部分进行互动,并且是其他肿瘤学和HIV临床试验小组的主要代表,AIDS癌症和标本资源(ACSR)和NIAID管理伙伴委员会。 Mitsuyasu博士将得到项目经理的协助,该项目经理将协调各个小组组件的功能,并将维护小组主席与网站,运营中心,统计中心和核心实验室之间的通信。她还将代表小组主席的工作组电话和审查协议,以获取准确性和完整性,然后再将其释放到网站。一名项目助理将安排并花几分钟的时间参加所有AMC电话会议,并为团体主席和项目经理履行秘书职责。项目分析师将负责监视小组财务的各个方面并为NCI准备财政报告。
恶性肿瘤是免疫缺陷HIV患者的日益严重的问题,癌症仍然是艾滋病患者发病和死亡率的主要原因之一。艾滋病恶性财团(AMC)进行了研究,以改善艾滋病毒疾病的癌症治疗。 AMC集团主席办公室负责协调和监督AMC功能的各个方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD T. MITSUYASU其他文献
RONALD T. MITSUYASU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD T. MITSUYASU', 18)}}的其他基金
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
印度艾滋病毒感染者癌症患病率、危险因素和结果的研究
- 批准号:
8710116 - 财政年份:2013
- 资助金额:
$ 25.01万 - 项目类别:
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
印度艾滋病毒感染者癌症患病率、危险因素和结果的研究
- 批准号:
8539193 - 财政年份:2013
- 资助金额:
$ 25.01万 - 项目类别:
South American Prevention of HIV Research Training Program (SAPHIR)
南美艾滋病毒预防研究培训计划 (SAPHIR)
- 批准号:
8474842 - 财政年份:2011
- 资助金额:
$ 25.01万 - 项目类别:
South American Prevention of HIV Research Training Program (SAPHIR)
南美艾滋病毒预防研究培训计划 (SAPHIR)
- 批准号:
8209934 - 财政年份:2011
- 资助金额:
$ 25.01万 - 项目类别:
South American Prevention of HIV Research Training Program (SAPHIR)
南美艾滋病毒预防研究培训计划 (SAPHIR)
- 批准号:
8309930 - 财政年份:2011
- 资助金额:
$ 25.01万 - 项目类别:
AMC Group Chairman, University of California, LA
AMC 集团董事长,加州大学洛杉矶分校
- 批准号:
8099873 - 财政年份:2010
- 资助金额:
$ 25.01万 - 项目类别:
UCLA-USC Combined Los Angeles Core Site
加州大学洛杉矶分校 (UCLA)-南加州大学 (USC) 联合洛杉矶核心站点
- 批准号:
8099881 - 财政年份:2010
- 资助金额:
$ 25.01万 - 项目类别:
A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR
Quadr 安全性和免疫原性的单臂、开放标签试点试验
- 批准号:
7951594 - 财政年份:2009
- 资助金额:
$ 25.01万 - 项目类别:
PHASE IIA TRIAL OF 1% TOPICAL CIDOFOVIR FOR TREATMENT OF HIGH-GRADE PERIANAL SQU
阶段%20IIA%20试验%20OF%201%%20局部%20西多福韦%20FOR%20治疗%20OF%20高等级%20肛周%20SQU
- 批准号:
8167120 - 财政年份:2009
- 资助金额:
$ 25.01万 - 项目类别:
相似海外基金
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
9249526 - 财政年份:2014
- 资助金额:
$ 25.01万 - 项目类别:
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
8826730 - 财政年份:2014
- 资助金额:
$ 25.01万 - 项目类别:
Islet Dysregulation in Infants with Congenital Hyperinsulinism
先天性高胰岛素血症婴儿的胰岛失调
- 批准号:
8764054 - 财政年份:2014
- 资助金额:
$ 25.01万 - 项目类别:
Proj. 4-The Genetic Variation of Innate Immune Genes w/Oral Manifestations of HIV
项目。
- 批准号:
8377539 - 财政年份:2012
- 资助金额:
$ 25.01万 - 项目类别: